WO1997015679B1 - Virus recombines contenant des elements genetiques mobiles et procedes d'utilisation desdits virus en therapie genique - Google Patents
Virus recombines contenant des elements genetiques mobiles et procedes d'utilisation desdits virus en therapie geniqueInfo
- Publication number
- WO1997015679B1 WO1997015679B1 PCT/US1996/017176 US9617176W WO9715679B1 WO 1997015679 B1 WO1997015679 B1 WO 1997015679B1 US 9617176 W US9617176 W US 9617176W WO 9715679 B1 WO9715679 B1 WO 9715679B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- original
- virus
- cell
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Abstract
L'invention concerne des adénovirus recombinés, avec délétion de E1, qui contiennent un transgène associé aux éléments d'une séquence de transposon recombiné, par ex., provenant du virus de la leucémie murine de Moloney (Mo-MLV), nécessaire pour effectuer une rétrotransposition spécifique du transgène à partir de l'adénovirus recombiné dans la chromatine de la cellule cible. L'invention concerne également des procédés de production desdits adénovirus recombinés et leurs procédés d'utilisation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU76653/96A AU7665396A (en) | 1995-10-27 | 1996-10-24 | Recombinant viruses containing mobile genetic elements and methods of use in gene therapy |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US594295P | 1995-10-27 | 1995-10-27 | |
| US60/005,942 | 1995-10-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO1997015679A1 WO1997015679A1 (fr) | 1997-05-01 |
| WO1997015679B1 true WO1997015679B1 (fr) | 1997-07-17 |
| WO1997015679A9 WO1997015679A9 (fr) | 1997-08-14 |
Family
ID=21718478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1996/017176 Ceased WO1997015679A1 (fr) | 1995-10-27 | 1996-10-24 | Virus recombines contenant des elements genetiques mobiles et procedes d'utilisation desdits virus en therapie genique |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7665396A (fr) |
| WO (1) | WO1997015679A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040510A1 (fr) | 1997-03-11 | 1998-09-17 | Regents Of The University Of Minnesota | Systeme transposon a base d'adn permettant d'introduire de l'acide nucleique dans l'adn d'une cellule |
| US7160682B2 (en) | 1998-11-13 | 2007-01-09 | Regents Of The University Of Minnesota | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell |
| US6576463B1 (en) * | 1999-01-15 | 2003-06-10 | The Regents Of The University Of California | Hybrid vectors for gene therapy |
| DE19909156A1 (de) | 1999-03-02 | 2000-09-07 | Aventis Res & Tech Gmbh & Co | Testsystem zum Nachweis einer Spleißreaktion, sowie dessen Verwendung |
| AU4711000A (en) * | 1999-05-11 | 2000-11-21 | Estuardo Aguilar-Cordova | Vector-mediated delivery of integrating transposon sequences |
| EP1238091A2 (fr) * | 1999-12-14 | 2002-09-11 | Genovo, Incorporated | Methodes et compositions destinees a la fabrication d'adenovirus incompetents pour la replication |
| WO2002092786A2 (fr) | 2001-03-26 | 2002-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Systeme de vecteurs adenoviraux dependants d'un auxiliaire, et methodes d'utilisation |
| AU2003231048A1 (en) | 2002-04-22 | 2003-11-03 | Regents Of The University Of Minnesota | Transposon system and methods of use |
| US7291604B2 (en) | 2003-09-03 | 2007-11-06 | The General Hospital Corporation | Methods of treating restenosis |
| AU2007221470B2 (en) | 2006-02-10 | 2013-02-14 | The University Of Cincinnati | Phosphatase inhibitor Protein-1 as a regulator of cardiac function |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03504079A (ja) * | 1988-03-21 | 1991-09-12 | カイロン コーポレイション | 組換えレトロウィルス |
| US6686200B1 (en) * | 1993-08-31 | 2004-02-03 | Uab Research Foundation | Methods and compositions for the large scale production of recombinant adeno-associated virus |
| FR2716893B1 (fr) * | 1994-03-03 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, leur préparation et leur utilisation thérapeutique. |
| AU3551195A (en) * | 1994-09-23 | 1996-04-09 | Somatix Therapy Corporation | Chimeric adenovirus for gene delivery |
-
1996
- 1996-10-24 AU AU76653/96A patent/AU7665396A/en not_active Abandoned
- 1996-10-24 WO PCT/US1996/017176 patent/WO1997015679A1/fr not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vile et al. | Retroviruses as vectors | |
| JP3886531B2 (ja) | レトロウイルスベクター | |
| Miyoshi et al. | Development of a self-inactivating lentivirus vector | |
| Hildinger et al. | Design of 5′ untranslated sequences in retroviral vectors developed for medical use | |
| Frecha et al. | Strategies for targeting lentiviral vectors | |
| Diaz et al. | A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy | |
| EP0953052B1 (fr) | Vecteurs retroviraux sans croisement | |
| US6013517A (en) | Crossless retroviral vectors | |
| WO1997015679B1 (fr) | Virus recombines contenant des elements genetiques mobiles et procedes d'utilisation desdits virus en therapie genique | |
| Kim et al. | Construction of retroviral vectors with improved safety, gene expression, and versatility | |
| Kurian et al. | Retroviral vectors | |
| AU2585395A (en) | Retroviral vectors having a reduced recombination rate | |
| KR950703649A (ko) | 결함 아데노비루스 벡터 및 유전자 치료에서 그의 사용 | |
| WO1997042338A9 (fr) | Vecteurs retroviraux sans croisement | |
| Uchida et al. | The chicken hypersensitivity site 4 core insulator blocks promoter interference in lentiviral vectors | |
| AU753809B2 (en) | Recombinant adenoviral vectors comprising a splicing sequence | |
| Froelich et al. | Lentiviral vectors for immune cells targeting | |
| Kerr et al. | Gene therapy: current status and future prospects | |
| He et al. | Recombinant lentivector as a genetic immunization vehicle for antitumor immunity | |
| US6565853B1 (en) | Recombinant virus | |
| EP0931157B1 (fr) | Vecteurs retroviraux | |
| JPH11507244A (ja) | Ｓｒｖ−３エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター | |
| Sadelain et al. | Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells | |
| CA2408786A1 (fr) | Vecteurs retroviraux comportant une structure renforcee de terminaison de transcription 3' | |
| Hurez et al. | Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction |